an intervention with drinking chamomile tea on sleep quality and depression in sleep disturbed postnatal women: a randomized controlled trial. J Adv Nurs. 2016;72(2):306–15. https://pubmed.ncbi.nlm.nih.gov/26483209/

830

Zemestani M, Rafraf M, Asghari-Jafarabadi M. Chamomile tea improves glycemic indices and antioxidants status in patients with type 2 diabetes mellitus. Nutrition. 2016;32(1):66–72. https://pubmed.ncbi.nlm.nih.gov/26437613/

831

Villa-Rodriguez JA, Aydin E, Gauer JS, Pyner A, Williamson G, Kerimi A. Green and chamomile teas, but not acarbose, attenuate glucose and fructose transport via inhibition of GLUT2 and GLUT5. Mol Nutr Food Res. 2017;61(12):1700566. https://pubmed.ncbi.nlm.nih.gov/28868668/

832

Bowen AJ, Reeves RL. Diurnal variation in glucose tolerance. Arch Intern Med. 1967;119(3):261–4. https://pubmed.ncbi.nlm.nih.gov/6019944/

833

Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev. 1997;18(5):716–38. https://pubmed.ncbi.nlm.nih.gov/9331550/

834

Bandín C, Scheer FA, Luque AJ, et al. Meal timing affects glucose tolerance, substrate oxidation and circadian-related variables: a randomized, crossover trial. Int J Obes (Lond). 2015;39(5):828–33. https://pubmed.ncbi.nlm.nih.gov/25311083/

835

Gibbs M, Harrington D, Starkey S, Williams P, Hampton S. Diurnal postprandial responses to low and high glycaemic index mixed meals. Clin Nutr. 2014;33(5):889–94. https://pubmed.ncbi.nlm.nih.gov/24135087/

836

3,2 км/ч. – Примеч. ред.

837

Colberg SR, Zarrabi L, Bennington L, et al. Postprandial walking is better for lowering the glycemic effect of dinner than pre-dinner exercise in type 2 diabetic individuals. J Am Med Dir Assoc. 2009;10(6):394–7. https://pubmed.ncbi.nlm.nih.gov/19560716/

838

Haxhi J, Scotto di Palumbo A, Sacchetti M. Exercising for metabolic control: is timing important? Ann Nutr Metab. 2013;62(1):14–25. https://pubmed.ncbi.nlm.nih.gov/23208206/

839

Reynolds AN, Mann JI, Williams S, Venn BJ. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia. 2016;59(12):2572–8. https://pubmed.ncbi.nlm.nih.gov/27747394/

840

Rahmadi A, Steiner N, Münch G. Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer’s disease. Clin Chem Lab Med. 2011;49(3):385–91. https://pubmed.ncbi.nlm.nih.gov/21275816/

841

Green AS. mTOR, glycotoxins and the parallel universe. Aging (Albany NY). 2018;10(12):3654–6. https://pubmed.ncbi.nlm.nih.gov/30540565/

842

Uribarri J, He JC. The low AGE diet: a neglected aspect of clinical nephrology practice? Nephron. 2015;130(1):48–53. https://pubmed.ncbi.nlm.nih.gov/25871778/

843

Yamagishi S, Nakamura K, Matsui T, Inoue H, Takeuchi M. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders. Med Hypotheses. 2007;69(3):666–8. https://pubmed.ncbi.nlm.nih.gov/17331665/

844

MIMS. Kremezin full prescribing information, dosage & side effects. https://www.mims.com/philippines/drug/info/kremezin?type=full. Accessed December 26, 2022.; https://www.mims.com/philippines/drug/info/kremezin?type=full

845

Uribarri J, Woodruff S, Goodman S, et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc. 2010;110(6):911–6.e12. https://pubmed.ncbi.nlm.nih.gov/20497781/

846

Cerami C, Founds H, Nicholl I, et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA. 1997;94(25):13915–20. https://pubmed.ncbi.nlm.nih.gov/9391127/

847

Green AS. mTOR, glycotoxins and the parallel universe. Aging (Albany NY). 2018;10(12):3654–6. https://pubmed.ncbi.nlm.nih.gov/30540565/

848

Green AS. mTOR, glycotoxins and the parallel universe. Aging (Albany NY). 2018;10(12):3654–6. https://pubmed.ncbi.nlm.nih.gov/30540565/

849

Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1561):9–16. https://pubmed.ncbi.nlm.nih.gov/21115525/

850

Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993;366(6454):461–4. https://pubmed.ncbi.nlm.nih.gov/8247153/

851

Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1561):9–16. https://pubmed.ncbi.nlm.nih.gov/21115525/

852

Partridge L, Harvey PH. Gerontology. Methuselah among nematodes. Nature. 1993;366(6454):404–5. https://pubmed.ncbi.nlm.nih.gov/8247143/

853

Мрачный жнец – образ смерти. – Примеч. ред.

854

Coffer P. OutFOXing the grim reaper: novel mechanisms regulating longevity by Forkhead transcription factors. Sci STKE. 2003;2003(201):PE39. https://pubmed.ncbi.nlm.nih.gov/14506287/

855

Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A. 2008;105(9):3438–42. https://pubmed.ncbi.nlm.nih.gov/18316725/

856

Kenyon C. The first long-lived mutants: discovery of the insulin/IGF-1 pathway for ageing. Philos Trans R Soc Lond B Biol Sci. 2011;366(1561):9–16. https://pubmed.ncbi.nlm.nih.gov/21115525/

857

Laron Z, Kauli R, Lapkina L, Werner H. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome. Mutat Res Rev Mutat Res. 2017;772:123–33. https://pubmed.ncbi.nlm.nih.gov/28528685/

858

Vitale G, Pellegrino G, Vollery M, Hofland LJ. Role of IGF-1 system in the modulation of longevity: controversies and new insights from a centenarians’ perspective. Front Endocrinol. 2019;10:27. https://pubmed.ncbi.nlm.nih.gov/30774624/

859

Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell. 2005;120(4):449–60. https://pubmed.ncbi.nlm.nih.gov/15734678/

860

Junnila RK, List EO, Berryman DE, Murrey JW, Kopchick JJ. The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol. 2013;9(6):366–76. https://pubmed.ncbi.nlm.nih.gov/23591370/

861

Vitale G, Barbieri M, Kamenetskaya M, Paolisso G. GH/IGF-I/insulin system in centenarians. Mech Ageing Dev. 2017;165(Pt B):107–14. https://pubmed.ncbi.nlm.nih.gov/27932301/

862

Vitale G, Brugts MP, Ogliari G, et al. Low circulating IGF-I bioactivity is associated with human longevity: findings in centenarians’ offspring. Aging (Albany NY). 2012;4(9):580–9. https://pubmed.ncbi.nlm.nih.gov/22983440/

863

Vitale G, Barbieri M, Kamenetskaya M, Paolisso G. GH/IGF-I/insulin system in centenarians. Mech Ageing Dev. 2017;165(Pt B):107–14. https://pubmed.ncbi.nlm.nih.gov/27932301/